Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Anti-CD19 therapy may help treat SLE and NMOSD.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Diet and lifestyle changes can help manage autoimmune diseases by reducing inflammation and supporting immune health.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Vitamin D is crucial for skin health and managing skin diseases.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Composite biomaterials can precisely control immune responses for better disease treatment.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.